Rouan Sarah Kathryn 4
4 · Viking Therapeutics, Inc. · Filed Jan 6, 2025
Insider Transaction Report
Form 4
Rouan Sarah Kathryn
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-01-02+18,800→ 18,800 totalExercise: $41.12From: 2026-01-02Exp: 2035-01-02→ Common Stock (18,800 underlying)